EVAR术后1年D-二聚体水平与持续性2型内漏患者瘤囊直径变化的相关性
该回顾性研究纳入74例EVAR术后持续性孤立性2型内漏且有1年D-二聚体数据的患者,随访中位37个月,观察到24例动脉瘤增大。1年D-二聚体≥5.5 µg/mL与5年内动脉瘤增大相关(HR 4.520,95%CI 1.056-19.349,P=0.042)。作者认为1年D-二聚体较高可能预测5年内动脉瘤增大,D-二聚体足够低时动脉瘤增大被认为不太可能。
要点
- 持续性孤立性2型内漏患者中,1年D-二聚体≥5.5 µg/mL与5年内动脉瘤增大独立相关(HR 4.520)。
- 动脉瘤增大组1年D-二聚体中位数12.30 µg/mL,显著高于其他组的7.62 µg/mL(P=0.024)。
- 作者认为1年D-二聚体较高可能预测5年内动脉瘤增大,D-二聚体足够低时增大不太可能。
核心结论
- 1年D-二聚体较高可能预测持续性2型内漏患者5年内动脉瘤增大。
- D-二聚体足够低时,动脉瘤增大被认为不太可能。
研究设计与样本
- 回顾性综述2007年6月至2020年2月间因肾下腹主动脉瘤行择期EVAR的病例。
- 持续性2型内漏定义为6个月和12个月增强CT随访均确认的2型内漏。
- 孤立性2型内漏定义为12个月内无其他类型内漏的2型内漏。
- 纳入随访>2年、持续性孤立性2型内漏且有1年D-二聚体数据的患者,排除12个月内任何再干预者。
- 最终纳入74例有1年D-二聚体数据的持续性孤立性2型内漏患者。
主要发现
- 中位随访37个月(IQR 25-60)期间观察到24例动脉瘤增大(定义为直径增加≥5 mm)。
- 动脉瘤增大组1年D-二聚体中位数为12.30(6.88-21.90)µg/mL,其他组为7.62(4.41-13.00)µg/mL,P=0.024。
- ROC曲线分析显示1年D-二聚体预测动脉瘤增大的最佳截断值为5.5 µg/mL(AUC=0.681)。
- 单因素分析中,成角瘤颈、肠系膜下动脉闭塞和1年D-二聚体≥5.5 µg/mL与动脉瘤增大显著相关(P分别为0.037、0.038和0.010)。
- Cox回归分析显示1年D-二聚体≥5.5 µg/mL与动脉瘤增大相关(P=0.042,HR 4.520,95%CI 1.056-19.349)。
关键数值与推荐
- 动脉瘤增大定义为直径增加≥5 mm。
- 1年D-二聚体预测动脉瘤增大的最佳截断值为5.5 µg/mL(AUC=0.681)。
- 1年D-二聚体≥5.5 µg/mL与动脉瘤增大的HR为4.520(95%CI 1.056-19.349,P=0.042)。
临床怎么用
- 作者认为1年D-二聚体较高可能预测持续性2型内漏患者5年内动脉瘤增大。
- 作者认为D-二聚体足够低时动脉瘤增大不太可能。
- 作者提出对未来增大可能性低的患者,或可考虑延迟随访,类似于瘤囊缩小的患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Recent studies suggested that continuous clotting renewal in thrombi plays a central role in sac enlargement after endovascular aneurysm repair (EVAR). We reviewed patients with persistent type 2 endoleak (T2EL) to estimate the impact of D-dimer level on sac enlargement. METHODS: A retrospective review of elective EVAR for infrarenal abdominal aortic aneurysm performed between June 2007 and February 2020. Persistent T2EL was defined as T2EL confirmed at both the 6 and 12 month contrast-enhanced computed tomography (CECT) follow-ups. "Isolated" T2EL was defined as T2EL without other types of endoleak within 12 months. Patients with >2 year follow-up, persistent isolated T2ELs, and D-dimer level data at 1 year (DD1Y) were included. Patients with any reintervention within 12 months were excluded. The association between DD1Y and aneurysm enlargement (AnE), defined as a ≥5 mm diameter increase, within 5 years was analyzed. Among 761 conventional EVAR, 515 patients had >2 years of follow-up. Thirty-three patients with any reintervention within 12 months and 127 patients without CECT at either 6 or 12 months were excluded. Among 131 patients with persistent isolated T2ELs, 74 patients with DD1Y data were enrolled. During a 37 month median follow-up [25-60, IQR], 24 AnEs were observed. In the AnE patients, the median DD1Y was significantly higher than that in the other patients (12.30 [6.88-21.90] vs 7.62 [4.41-13.00], P=0.024). ROC curve analysis indicated that the optimal cutoff point of DD1Y for AnE was 5.5 µg/mL (AUC=0.681). In univariate analysis, angulated neck, occlusion of the inferior mesenteric artery, and DD1Y≥5.5 µg/mL were significantly associated with AnE (P= 0.037, 0.038, and 0.010). Cox regression analysis revealed that DD1Y≥5.5 µg/mL was correlated with AnE (P=0.042, HR [95% CI] 4.520 [1.056-19.349]). CONCLUSION: A 1 year higher D-dimer level can potentially predict AnE within 5 years in persistent T2EL patients. AnE was considered improbable when the D-dimer level was low enough.Clinical ImpactThe present study suggests that a 1-year higher D-dimer level could potentially predict aneurysm expansion within 5 years in patients with persistent type 2 endoleak (T2EL). On the other hand, aneurysm expansion was considered unlikely if the D-dimer level was low enough.As there are many patients with T2EL who require regular follow-up, any predictor of future aneurysm expansion could be of great help in conserving medical resources. In patients with a low likelihood of future expansion, we might consider delaying follow-up, similar to patients with sac shrinkage.
引用
- Sugimoto M, Sato T, Ikeda S, et al. The Association Between the D-dimer Level at 1 Year After EVAR and Sac Diameter Change in Patients With Persistent Type 2 Endoleak. J Endovasc Ther. 2023. PMID: 37096766. doi:10.1177/15266028231170165
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。